Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

Clinical trial NCT06806228 · SUSPENDED

Trial details

NCT number: NCT06806228
Sponsor: Petrov, Andrey
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme Diffuse Midline Glioma, H3 K27M-Mutant Gliosarcoma Giant Cell Glioblastoma GBM

Start date: 2026-05-20
Primary completion: 2027-10-10
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.